Immix Biopharma
IMMX
IMMX
31 hedge funds and large institutions have $8.77M invested in Immix Biopharma in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$282K | |
| 2 | +$249K | |
| 3 | +$57.2K | |
| 4 |
Squarepoint
New York
|
+$45.6K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$34.4K |
Top Sellers
| 1 | -$294K | |
| 2 | -$236K | |
| 3 | -$219K | |
| 4 |
CCM
Corsair Capital Management
New York
|
-$109K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$75.3K |